Treatment and rehabilitation for cervical cancer: the experience of patient journey management
A. A. Akavova,
A. G. Solopova,
D. V. Blinov,
E. E. Achkasov,
V. N. Galkin,
D. I. Korabelnikov,
A. N. Mnatsakanyan,
D. A. Petrenko,
G. K. Bykovshchenko,
P. L. Khazan https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.461
Abstract
Radical surgical intervention, chemoradiotherapy and immune therapy implicated for patients with cervical cancer (CC) can result in significant morphofunctional, psychological, sexual disorders and social maladjustment. To optimize treatment and rehabilitation for CC patients, a routing approach has been established. This approach involves the patient's journey during diagnosis and treatment with well-defined timed stages. Additionally, a rehabilitation program with lifelong follow-up has been implemented. Prior to commencing therapy, undertaking rehabilitation after oncogynecological treatment during the stage spanning from diagnosis to therapy initiation contributes to enhancing the quality of life (QoL) for CC patients.
About the Authors
A. A. Akavova
City Clinical Oncological Hospital No. 1
Russian Federation
Russian Federation
Saida A. Akavova – MD, Oncologist, Head of Outpatient Care Cente
18A bldg. 7, Zagorodnoe Shosse, Moscow 117152
A. G. Solopova
Sechenov University
Russian Federation
Russian Federation
Antonina G. Solopova – MD, Dr Sci Med, Professor, Department of Obstetrics, Gynecology and Perinatal Medicine, Filatov Clinical Institute of Children’s Health
2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991
D. V. Blinov
Sechenov University; Institute for Preventive and Social Medicine; Moscow Haass Medical – Social Institute
Russian Federation
Russian Federation
Dmitry V. Blinov – MD, PhD, MBA, Assistant, Department of Sports Medicine and Medical Rehabilitation, Sklifosovsky Institute of Clinical Medicine, Sechenov University; Head of Medical and Scientific Affairs, Institute for Preventive and Social Medicine; Associate Professor, Department of Sports, Physical and Rehabilitation Medicine, Moscow Haass Medical – Social Institute
Scopus Author ID: 6701744871
Researcher ID: E-8906-2017
RSCI: 9779-8290
2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991
4–10 Sadovaya-Triumfalnaya Str., Moscow 127006
5 bldg. 1–1a, 2-ya Brestskaya Str., Moscow 123056
E. E. Achkasov
Sechenov University
Russian Federation
Russian Federation
Evgeniy E. Achkasov – MD, Dr Sci Med, Professor, Head of the Department of Sports Medicine and Rehabilitation, Sklifosovsky Institute of Clinical Medicine, Director of the Clinic for Medical Rehabilitation
2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991
V. N. Galkin
City Clinical Oncological Hospital No. 1
Russian Federation
Russian Federation
Vsevolod N. Galkin – MD, Dr Sci Med, Professor, Chief Physician
18A bldg. 7, Zagorodnoe Shosse, Moscow 11715
D. I. Korabelnikov
Moscow Haass Medical – Social Institute
Russian Federation
Russian Federation
Daniil I. Korabelnikov – MD, PhD, Professor, Department of Internal Medicine with Courses in Family Medicine, Functional Diagnostics, Infectious Diseases, Rector
5 bldg. 1–1a, 2-ya Brestskaya Str., Moscow 123056
A. N. Mnatsakanyan
Bauman Moscow State Technical University (National Research University)
Russian Federation
Russian Federation
Anna N. Mnatsakanyan – MD, PhD, Associate Professor, L2 Department
5 bldg. 1, 2-ya Baumanskaya Str., Moscow 105005
D. A. Petrenko
Sechenov University
Russian Federation
Russian Federation
Daria A. Petrenko – MD, Clinical Resident, Department of Clinical Pharmacology and Propaedeutics of Internal Diseases
2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991
G. K. Bykovshchenko
Sechenov University
Russian Federation
Russian Federation
Georgy K. Bykovshchenko – 6th year Student
2 bldg. 4, Bolshaya Pirogovskaya Str., Moscow 119991
P. L. Khazan
Lopatkin Research Institute of Urology and Interventional Radiology – Branch of National Medical Research Radiological Centre
Russian Federation
Russian Federation
Peter L. Khazan – MD, PhD, Urologist, Clinical Pharmacologist, Senior Researcher, Group of Inflammatory Diseases and Clinical Pharmacology
51 bldg. 1, 3-ya Parkovaya Str., Moscow 105425
References
1. Sung H., Ferlay J., Siegel R.L. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021;71(3):209–49. https://doi.org/10.3322/caac.21660.
2. Soerjomataram I., Bray F. Planning for tomorrow: global cancer incidence and the role of prevention 2020–2070. Nat Rev Clin Oncol. 2021;18(10):663–72. https://doi.org/10.1038/s41571-021-00514-z.
3. The state of oncological care for the Russian population in 2021. Eds. A.D. Kaprin, V.V. Starinsky, A.O. Shakhzadova. [Costoyanie onkologicheskoj pomoshchi naseleniyu Rossii v 2021 godu. Pod red. A.D. Kaprina, V.V. Starinskogo, A.O. Shahzadovoj]. Moscow: Hertsen Moscow Oncology Research Institute – Branch of National Medical Research Radiological Centre, 2022. 239 p. (In Russ.). Available at: https://oncology-association.ru/wp-content/uploads/2022/05/sostoyanie-onkologicheskoj-pomoshhinaseleniyu-rossii-v-2021-godu.pdf. [Accessed: 25.08.2023].
4. European Health Information Portal. Incidence of cervical cancer. [Evropejskij portal informacii zdravoohraneniya. Zabolevaemost' rakom shejki matki]. (In Russ.). Available at: https://gateway.euro.who.int/ru/ indicators/hfa_377-2360-incidence-of-cervix-uteri-cancer-per-100-000/?id=19308&fullGraph=true. [Accessed: 25.08.2023].
5. Clinical guidelines. Cervical cancer. [Klinicheskie rekomendacii. Rak shejki matki]. Мoscow: Ministerstvo zdravoohraneniya Rossijskoj Federacii, 2020. 66 p. (In Russ.). Available at: https://oncology-association.ru/ wp-content/uploads/2020/09/rak_shejki_matki.pdf. [Accessed: 25.08.2023].
6. Khokhlova S.V., Kolomiets L.A., Kravets O.A. et al. Practical recommendations for drug treatment of cervical cancer. Malignant tumors: Practical recommendations RUSSCO #3s2. [Prakticheskie rekomendacii po lekarstvennomu lecheniyu raka shejki matki. Zlokachestvennye opuholi: Prakticheskie rekomendacii RUSSCO #3s2]. 2021;11:197–217. (In Russ.). https://doi.org/10.18027/2224-5057-2021-11-3s2-13.
7. Smith E.S., Moon A.S., O'Hanlon R. et al. Radical trachelectomy for the treatment of early-stage cervical cancer: a systematic review. Obstet Gynecol. 2020;136(3):533–42. https://doi.org/10.1097/AOG.0000000000003952.
8. Kuznicki M.L., Chambers L.M., Morton M. et al. Fertility-sparing surgery for early-stage cervical cancer: a systematic review of the literature. J Minim Invasive Gynecol. 2021;28(3):513–526.e1. https://doi.org/10.1016/j.jmig.2020.10.013.
9. Okugawa K., Yahata H., Ohgami T. et al. An update of oncologic and obstetric outcomes after abdominal trachelectomy using the FIGO 2018 staging system for cervical cancer: a single-institution retrospective analysis. J Gynecol Oncol. 2023;34(3):e41. https://doi.org/10.3802/jgo.2023.34.e41.
10. Bhatla N., Tomar S., Meena J. et al. Adjuvant treatment in cervical, vaginal and vulvar cancer. Best Pract Res Clin Obstet Gynaecol. 2022;78:36–51. https://doi.org/10.1016/j.bpobgyn.2021.07.005.
11. Dyer B.A., Feng C.H., Eskander R. et al. Current status of clinical trials for cervical and uterine cancer using immunotherapy combined with radiation. Int J Radiat Oncol Biol Phys. 2021;109(2):396–412. https://doi.org/10.1016/j.ijrobp.2020.09.016.
12. Rubinstein M.M., Makker V. Optimizing immunotherapy for gynecologic cancers. Curr Opin Obstet Gynecol. 2020;32(1):1–8. https://doi.org/10.1097/GCO.0000000000000603.
13. Corte L.D., Barra F., Foreste V. et al. Advances in paclitaxel combinations for treating cervical cancer. Expert Opin Pharmacother. 2020;21(6):663– 77. https://doi.org/10.1080/14656566.2020.1724284.
14. Tewari K.S., Sill M.W., Long H.J. et al. Improved survival with bevacizumab in advanced cervical cancer. N Engl J Med. 2014;370(8):734–43. https://doi.org/10.1056/NEJMoa1309748.
15. Blinov D.V., Solopova A.G., Plutnitskiy A.N. et al. Strengthening health care to provide rehabilitation services for women with cancer diseases of the reproductive system. [Organizaciya zdravoohraneniya v sfere reabilitacii pacientok s onkologicheskimi zabolevaniyami reproduktivnoj sistemy]. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(1):119–30. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.132.
16. Seland M., Skrede K., Lindemann K. et al. Distress, problems and unmet rehabilitation needs after treatment for gynecological cancer. Acta Obstet Gynecol Scand. 2022;101(3):313–22. https://doi.org/10.1111/aogs.14310.
17. Lev-Sagie A. Vulvar and vaginal atrophy: physiology, clinical presentation, and treatment considerations. Clin Obstet Gynecol. 2015;58(3):476–91. https://doi.org/10.1097/GRF.0000000000000126.
18. Nappi R.E., Palacios S., Panay N. et al. Vulvar and vaginal atrophy in four European countries: evidence from the European REVIVE Survey. Climacteric. 2019;19(2):188–97. https://doi.org/10.3109/13697137.2015.1107039.
19. Krychman M., Graham S., Bernick B. et al. The women's EMPOWER survey: women's knowledge and awareness of treatment options for vulvar and vaginal atrophy remains inadequate. J Sex Med. 2017;14(3):425–33. https://doi.org/10.1016/j.jsxm.2017.01.011.
20. Zhang J., Ju X., Feng Z. et al. Progressive resistance exercise training to prevent lower-limb lymphedema after cervical cancer surgery: a feasibility study. Asia Pac J Oncol Nurs. 2021;9(1):32–8. https://doi.org/10.1016/j.apjon.2021.12.002.
21. Pieterse Q.D., Kenter G.G., Maas C.P. et al. Self-reported sexual, bowel and bladder function in cervical cancer patients following different treatment modalities: longitudinal prospective cohort study. Int J Gynecol Cancer. 2013;23(9):1717–25. https://doi.org/10.1097/IGC.0b013e3182a80a65.
22. Bona A.F., Ferreira K.R., de Moura Carvalho R.B. et al. Incidence, prevalence, and factors associated with lymphedema after treatment for cervical cancer: a systematic review. Int J Gynecol Cancer. 2020;30(11):1697–704. https://doi.org/10.1136/ijgc-2020-001682.
23. Hu H., Fu M., Huang X. et al. Risk factors for lower extremity lymphedema after cervical cancer treatment: a systematic review and meta-analysis. Transl Cancer Res. 2022;11(6):1713–21. https://doi.org/10.21037/tcr-22- 1256.
24. Sycheva I.V. Radiation injuries of the pelvic organs in oncogynecological patients and their treatment. Certificate of registration of the database RU RU2020620609, 27.03.2020. Application No. 2020620908 dated of 19.06.2020. Computer programs. Databases. Topologies of integrated circuits. [Luchevye povrezhdeniya organov malogo taza u onkoginekologicheskih bol'nyh i ih lechenie. Cvidetel'stvo o registracii bazy dannyh RU RU2020620609, 27.03.2020. Zayavka №2020620908 ot 19.06.2020. Programmy EVM. Bazy dannyh. Topologii integral'nyh mikroskhem]. Moscow: Federal'nyj institut promyshlennoj sobstvennosti. 2020;(4):99–105. (In Russ.).
25. Fawaz Z.S., Barkati M., Beauchemin M.C. et al. Cervical necrosis after chemoradiation for cervical cancer: case series and literature review. Radiat Oncol. 2013;8:220. https://doi.org/10.1186/1748-717X-8-220.
26. Kirchheiner K., Fidarova E., Nout R.A. et al. Radiation-induced morphological changes in the vagina. Strahlenther Onkol. 2012;188(11):1010–7. https://doi.org/10.1007/s00066-012-0222-0.
27. Leiper K., Morris A.I. Treatment of radiation proctitis. Clin Oncol (R Coll Radiol). 2007;19(9):724–9. https://doi.org/10.1016/j.clon.2007.07.008.
28. Barker C.L., Routledge J.A., Farnell D.J. et al. The impact of radiotherapy late effects on quality of life in gynaecological cancer patients. Br J Cancer. 2009;100(10):1558–65. https://doi.org/10.1038/sj.bjc.6605050.
29. Ji J., Zhu H., Zhao J.Z. et al. Negative emotions and their management in Chinese convalescent cervical cancer patients: a qualitative study. J Int Med Res. 2020;48(9):300060520948758. https://doi.org/10.1177/0300060520948758.
30. Mantegna G., Petrillo M., Fuoco G. et al. Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis. BMC Cancer. 2013;13:127. https://doi.org/10.1186/1471-2407-13-127.
31. Park S.Y., Bae D.S., Nam J.H. et al. Quality of life and sexual problems in disease-free survivors of cervical cancer compared with the general population. Cancer. 2007;110(12):2716–25. https://doi.org/10.1002/cncr.23094.
32. Bjelic-Radisic V., Jensen P.T., Vlasic K.K. et al. Quality of life characteristics inpatients with cervical cancer. Eur J Cancer. 2012;48(16):3009–18. https://doi.org/10.1016/j.ejca.2012.05.011.
33. Froeding L.P., Ottosen C., Rung-Hansen H. et al. Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study. J Sex Med. 2014;11(2):595–604. https://doi.org/10.1111/jsm.12399.
34. Wiegel M., Meston C., Rosen R. The female sexual function index (FSFI): cross-validation and development of clinical cutoff scores. J Sex Marital Ther. 2005;31(1):1–20. https://doi.org/10.1080/00926230590475206.
35. Liu Z., Shi H. Prognostic role of squamous cell carcinoma antigen in cervical cancer: a meta-analysis. Dis Markers. 2019;2019:6710352. https://doi.org/10.1155/2019/6710352.
36. Prilepskaya V.N. HPV-associated cervical diseases: screening, methods of examination, principles of treatment. [VPCh-associirovannye zabolevaniya shejki matki: skrining, metody obsledovaniya, principy lecheniya]. Ginekologiya. 2019;21(3):6–8. (In Russ.). https://doi.org/10.26442/20795 696.2019.3.190595.
37. Begovich E., Solopova A.G., Khlopkova S.V. et al. Possibilities and prospects for epigenetic rehabilitation in patients with external form of genital endometriosis. [Vozmozhnosti i perspektivy epigeneticheskoj reabilitacii u pacientok s naruzhnoj formoj genital'nogo endometrioza]. Vrach. 2022;33(5):5–8. (In Russ.). https://doi.org/10.29296/25877305- 2022-05-01.
38. Vlasina A.Yu., Solopova A.G., Ivanova E.A., Blbulyan T.A. Anticancer diet, or the principles of rational nutrition in gynecological cancer patients duringe rehabilitation. [«Protivorakovaya dieta», ili principy racional'nogo pitaniya onkoginekologicheskih bol'nyh v period reabilitacii]. Vrach. 2020;31(4):3– 7. (In Russ.). https://doi.org/10.29296/25877305-2020-04-01.
39. Li X., Liu L., He J. et al. Analysis of the effectiveness of the application of pelvic floor rehabilitation exercise and the factors influencing its selfefficacy in postoperative patients with cervical cancer. Front Oncol. 2023;13:1118794. https://doi.org/10.3389/fonc.2023.1118794.
40. Li H., Zhou C.K., Song J et al. Curative efficacy of low frequency electrical stimulation in preventing urinary retention after cervical cancer operation. World J Surg Oncol. 2019;17(1):141. https://doi.org/10.1186/s12957-019-1689-2.
41. Cullen K., Fergus K., DasGupta T. et al. Toward clinical care guidelines for supporting rehabilitative vaginal dilator use with women recovering from cervical cancer. Support Care Cancer. 2013;21(7):1911–7. https://doi.org/10.1007/s00520-013-1726-6.
42. Sacomori C., Araya-Castro P., Diaz-Guerrero P. et al. Pre-rehabilitation of the pelvic floor before radiation therapy for cervical cancer: a pilot study. Int Urogynecol J. 2020;31(11):2411–8. https://doi.org/10.1007/s00192-020-04391-5.
43. Huang Y.-C., Chang K.-V. Kegel Exercises. In: StatPearls. Treasure Island (FL): StatPearls Publishing; May 1, 2023.
44. Wu X., Liu Y., Zhu D. et al. Early prevention of complex decongestive therapy and rehabilitation exercise for prevention of lower extremity ymphedema after operation of gynecologic cancer. Asian J Surg. 2021;44(1):111–5. https://doi.org/10.1016/j.asjsur.2020.03.022.
45. Cross D., Waheed N., Krake M., Gahreman D. Effectiveness of supervised Kegel exercises using bio-feedback versus unsupervised Kegel exercises on stress urinary incontinence: a quasi-experimental study. Int Urogynecol J. 2023;34(4):913–20. https://doi.org/10.1007/s00192-022-05281-8.
46. Makatsariya A.D., Blinov D.V., Bitsadze V.O., Khizroeva J.K. Treatment of postmenopausal vulvovaginal atrophy with estriol: a scientific update for 2014–2018. [Lechenie estriolom vul'vovaginal'noj atrofii v postmenopauze: obnovlenie nauchnyh dannyh 2014–2018 gg.]. Obstetrics, Gynecology and Reproduction. 2019;13(3):227–38. (In Russ.). https://doi.org/10.17749/2313-7347.2019.13.3.227-238.
47. Shi Y., Cai J., Wu Z. et al. Effects of a nurse-led positive psychology intervention on sexual function, depression and subjective well-being in postoperative patients with early-stage cervical cancer: A randomized controlled trial. Int J Nurs Stud. 2020;111:103768. https://doi.org/10.1016/j.ijnurstu.2020.103768.
48. Solopova A.G., Blinov D.V., Begovich E. et al. Neurological disorders after hysterectomy: from pathogenesis to clinical manifestations. [Nevrologicheskie rasstrojstva posle gisterektomii: ot patogeneza k klinike]. Epilepsy and paroxysmal conditions. 2022;14(1):54–64. (In Russ.). https://doi.org/10.17749/2077-8333/epi.par.con.2022.115.
49. Solopova A.G., Blinov D.V., Demyanov S.V. et al. Epigenetic aspects in rehabilitation of female cancer patients. [Epigeneticheskie aspekty reabilitacii onkoginekologicheskih bol'nyh]. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2022;15(2):294–303. (In Russ.). https://doi.org/10.17749/2070-4909/farmakoekonomika.2022.141.
Review
For citations:
Akavova A.A., Solopova A.G., Blinov D.V., Achkasov E.E., Galkin V.N., Korabelnikov D.I., Mnatsakanyan A.N., Petrenko D.A., Bykovshchenko G.K., Khazan P.L. Treatment and rehabilitation for cervical cancer: the experience of patient journey management. Obstetrics, Gynecology and Reproduction. 2023;17(5):625-637. (In Russ.) https://doi.org/10.17749/2313-7347/ob.gyn.rep.2023.461
Views:
1812
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
